Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Antiulcer activity of cromakalim

April 17, 1997

Mechanism of HCV resistance to interferon discovered

April 16, 1997

Milestone reached in Genome Therapeutics/Astra H. pylori collaboration

April 11, 1997

Encouraging phase III results reported for lamivudine as hepatitis B treatment

April 11, 1997

Taisho/Ikeda Mohando describe anti-H. pylori agent

April 9, 1997

Fujisawa reports antiulcer agents

April 9, 1997

5-LO inhibitor not effective as monotherapy in active ulcerative colitis

April 7, 1997

Positive phase III results reported for Centocor's Crohn's disease treatment

April 7, 1997

Court rules in favor of Novopharm regarding generic ranitidine product

April 7, 1997

Budesonide cleared in Canada for Crohn's disease

April 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...